Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1467-1476

  Radcliffe, Richard A ^a   Erwin, V Gene ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; EPIDEPRIDE; HOMOVANILLIC ACID; NEUROTENSIN; NEUROTENSIN RECEPTOR; NORADRENALIN; SEROTONIN; VANOXERINE;

ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN TISSUE; LOCOMOTION; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MICE; MICE, INBRED STRAINS; MICROINJECTIONS; PIPERAZINES; PREFRONTAL CORTEX;

EID: 0030440905     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. ALTAR, C. A., BOYAR, W. C., OEI, E. AND WOOD, P. L.: Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices. J. Pharmacol. Exp. Ther. 242: 115-120, 1987.
2. AUDINAT, E., HERMEL, J. M. AND CREPEL, F.: Neurotensin-induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro. Exp. Brain Res. 78: 358-68, 1989.
3. BEAN, A. J., ADRIAN, T. E., MODLIN, I. M. AND ROTH, R. H.: Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations. J. Pharmacol. Exp. Ther. 249: 681-687, 1989a.
4. BEAN, A. J., DURING, M. J. AND ROTH, R. H.: Stimulation-induced release of coexistent transmitters in the prefrontal cortex: An in vivo microdialysis study of dopamine and neurotensin release. J. Neurochem. 53: 655-7, 1989b.
5. BEAN, A. J. AND ROTH, R. H.: Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: Effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J. Neurosci. 11: 2694-702, 1991.
6. BEAUBEGARD, M., FEREON, A. AND DESCARRIES, L.: Possible existence of a presynaptic positive feedback mechanism enhancing dopamine transmission in the anterior cingulate cortex of the rat. Experientia (Basel) 45: 888-892, 1989.
7. BEAUREGARD, M., FERRON, A. AND DESCARRIES, L.: Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: An iontophoretic study. Neuroscience 47: 613-619, 1992.
8. BERGER, B., THIERRY, A. M., TASSIN, J. P. AND MOYNE, M. A.: Dopaminergic innervation of the rat prefrontal cortex: A fluorescence histochemical study. Brain Res. 106: 133-145, 1976.
9. 125I]iodosulpride. Neuroscience 20: 117-155, 1987.
10. BOYSON, S. J., MCGONIGLE, P. AND MOLINOFF, P. B.: Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J. Neurosci. 8: 3177-3188, 1986.
11. BRAUN, A. R., JASKIW, G. E., VLADAR, K., SEXTON, R. H., KOLACHANA, B. S. AND WEINBERGER, D. R.: Effects of ibotenic acid lesion of the medial prefrontal cortex on dopamine agonist-related behaviors in the rat. Pharmacol. Biochem. Behav. 46: 51-60, 1993.
12. BUBSER, M. AND SCHMIDT, W. J.: 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav. Brain Res. 37: 157-68, 1990.
13. CAMPBELL, A. D., JONES, B. C. AND ERWIN, V. G.: Regional characterization of brain neurotensin receptor subtypes in LS and SS mice. Alcohol Clin. Exp. Res. 15: 1011-1017, 1991.
14. CARR, G. D. AND WHITE, N. M.: Effects of systemic and intracranial amphetamine injections on behavior in the open field: A detailed analysis. Pharmacol. Biochem. Behav. 27: 113-122, 1987.
15. CARTER, C. J.: Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacology 21: 379-383, 1982.
16. CARTER, C. J. AND PYCOCK, C. J.: Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 192: 163-76, 1980.
17. CHARUCHINDA, C., SUPAVILAJ, P., KAROBATH, M. AND PALACIOS, J. M.: Dopamine D2 receptors in the rat brain: Autoradiographic visualization using a high-affinity selective agonist ligand. J. Neurosci. 7: 1352-1360, 1987.
18. CHERAMY, A., ROMO, R., GODEHEU, G., BARUCH, P. AND GLOWINSKI, J.: In vivo presynaptic control of dopamine release in the cat caudate nucleus. I. Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19: 1081-1090, 1986.
19. CLARK, D. AND WHITE, F. J.: D1 dopamine receptor - The search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse 1: 347-88, 1987.
20. CUBEDDU, L. X., HOFFMANN, I. S. AND TALMACIU, R. K.: Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals. Ann. N.Y. Acad. Sci. 604: 452-61, 1990.
21. DEUTCH, A. Y.: The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. Suppl. 36: 61-89, 1992.
22. DEUTCH, A. Y., CLARK, W. A. AND ROTH, R. H.: Prefrontal cortical dopamine depletion enhances the responaiveness of mesolimbic dopamine neurons to stress. Brain Res. 521: 311-315, 1990.
23. DI CHIARA, G., TANDA, G. L., FRAU, R. AND CARBONI, E.: Heterologous monoamiue reuptake: Lack of transmitter specificity of neuron-specific carriers. Neurochem. Int. 20: (Suppl.) 231S-235S, 1992.
24. ELSWORTH, J. D., TAYLOR, J. R., BERGER, P. AND ROTH, R. H.: Cocaine-sensitive and -insensitive dopamine uptake in prefrontal cortex, nucleus accumbens and striatum. Neurochem. Int. 23: 61-69, 1993.
25. ERVIN, G. N., BIRKEMO, L. S., NEMEROFF, C. B. AND PRANGE, A. J., JR.: Neurotensin blocks certain amphetamine-induced behaviours. Nature (Lond.) 291: 73-76, 1981.
26. ERWIN, V. G., JONES, B. C. AND MYERS, R.: Effects of acute and chronic ethanol administration on neurotensinergic systems. Ann. N.Y Acad. Sci. 739: 185-196, 1994.
27. ERWIN, V. G., JONES, B. C. AND RADCLIFFE, R.: Further characterization of LS×SS recombinant inbred strains of mice: Activating and hypothermic effects of ethanol [published erratum appears in Alcohol Clin. Exp. Res. 1990 Aug; 14: 573]. Alcohol Clin. Exp. Res. 14: 200-204, 1990.
28. ERWIN, V. G., WOMER, D. E., CAMPBELL, A. D. AND JONES, B. C.: Pharmacogenetics of cocaine. II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice. Pharmacogenetics 8: 189-196, 1993.
29. 3H-R(+)SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. Biochem. Pharmacol. 38: 473-480, 1989.
30. GALLOWAY, M. P., WOLF, M. E. AND ROTH, R. H.: Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: Studies in vivo. J. Pharmacol. Exp. Ther. 236: 689-698, 1986.
31. GIORGUIEFF, M. F., KEMEL, M. L. AND GLOWINSKI, J.: Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci. Lett. 6: 73-77, 1977.
32. GIHAULT, J. A., BARBEITO, L., SPAMPINATO, U., GOZLAN, H., GLOWINSKI, J. AND BESSON, M. J.: In vivo release of endogenous amino acids from the rat striatum: Further evidence for a role of glutamate and aspartate in corticostriatal neurotransmission. J. Neurochem. 47: 98-106, 1986.
33. GODBOUT, R., MANTZ, J., PIROT, S., GLOWINSKI, J. AND THIERRY, A. M.: Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: Electrophysiological and pharmacological characterization. J. Pharmacol. Exp. Ther. 258: 728-738, 1991.
34. GOEDERT, M., PITTAWAY, K., WILLIAMS, B. J. AND EMSON, P. C.: Specific binding of tritiated neurotensin to rat brain membranes: Characterization and regional distribution. Brain Res. 304: 71-81, 1984.
35. GOLDMAN-RAKIC, P. S., LERANTH, C., WILLIAMS, S. M., MONS, N. AND GEFFARD, M.: Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 86: 9015-9019, 1989.
36. HEIKKILA, R. E. AND MANZINO, L.: Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103: 241-248, 1984.
37. 3H]GBR 12935 binding in the human and rat frontal cortex. J. Neurochem. 66: 1663-1672, 1991.
38. HOLSON, R. R. AND WALKER, C.: Mesial prefrontal cortical lesions and timidity in rats. II. Reactivity to novel stimuli. Physiol. Behav. 37: 231-238, 1986.
39. HOOKS, M. S., JONES, G. H., LIEM, B. J. AND JUSTICE, J. B., JR.: Sensitization and individual differences to i.p. amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions. Pharmacol. Biochem. Behav. 43: 815-823, 1992.
40. HOOKS, M. S., JUNCOS, J. L., JUSTICE, J. B., JR.,MEIERGERD, S. M., POVLOCK, S. L., SCHENK, J. O. AND KALIVAS, P. W.: Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J. Neurosci. 14: 6144-6152, 1994.
41. IZENWASSER, S., WERLING, L. L. AND Cox, B. M.: Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res. 520: 303-309, 1990.
42. JASKIW, G. E., KAROUM, F., FREED, W. J., PHILLIPS, I., KLEINMAN, J. E. AND WEINBERGER, D. R.: Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res. 534: 263-72, 1990a.
43. JASKIW, G. E., KAROUM, F. K AND WEINBERGER, D. R.: Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex. Brain Res. 534: 321-323, 1990b.
44. JASKIW, G. E., WEINBERGER, D. R. AND CRAWLEY, J. N.: Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biol. Psychiatry 29: 703-706, 1991.
45. JONES, G. H. AND ROBBINS, T. W.: Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity. Pharmacol. Biochem. Behav. 43: 887-895, 1992.
46. KALIVAS, P. W., BURGESS, S. K., NEMEROFF, C. B. AND PRANGE, A. J., JR.: Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 8: 495-505, 1983.
47. KALIVAS, P. W., NEMEROFF, C. B. AND PRANGE, A. J.: Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience 11: 919-930, 1984.
48. KAROUM, F., CHRAPUSTA, S. J., BRINJAK, R., HITRI, A. AND WYATT, R. J.: Regional effects of amphetamine, cocaine, nomifensine and GBR12909 on the dynamics of dopamine release and metabolism in the rat brain. Br. J. Pharmacol. 113: 1391-1399, 1994.
49. KELLEY, A. E. AND THRONE, L. C.: NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29: 247-254, 1992.
50. 125I]Epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Life Sci. 49: 617-628, 1991.
51. LOUILOT, A., LE MOAL, M. AND SIMON, H.: Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study. Neuroscience 29: 45-56, 1989.
52. LOWRY, O. H., ROSEBHOUGH, J. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin reagent. J. Biol. Chem. 193: 265-275, 1951.
53. LUTHMAN, J., FREDRIKSSON, A., LEWANDER, T., JONSSON, G. AND AKCHER, T.: Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology 99: 550-557, 1989.
54. 3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats. J. Pharmacol. Exp. Ther. 270: 133-141, 1994.
55. MCCLEARN, G. E. AND KAKIHANA, R.: Selective breeding for ethanol sensitivity: Short-sleep and long-sleep mice. In Development of Animal Models as Pharmacogenetic Tools, ed. by G. E. McClearn, R. A. Deitrich and V. G. Erwin, U.S. Government Printing Office, Washington, 1981.
56. MCGEER, P. L., MCGEER, E. G., SCHERER, U. AND SINGK, K.: A glutamatergic corticostriatal path? Brain Res. 128: 369-373, 1977.
57. MORENCY, M. A., STEWART, R. J. AND BENINGER, R. J.: Effects of unilateral microinjections of sulpiride into the prefrontal cortex on circling behavior of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 9: 735-738, 1985.
58. MORENCY, M. A., STEWART, R. J. AND BENINGER, R. J.: Circling behavior following unilateral microinjections of cocaine into the medial prefrontal cortex: Dopaminergic or local anesthetic effect? J. Neurosci. 7: 812-818, 1987.
59. NEMEROFF, C. B., BISSETTE, G., PRANGE, A. J., JR., LOOSEN, P. T., BARLOW, T. S. AND LIPTON, M. A. Neurotensin: Central nervous system effects of a hypothalamic peptide. Brain Res. 128: 485-96, 1977.
60. 125I]epidepride, a high-affinity substituted benzamide ligand. J. Pharmacol. Exp. Ther. 252: 1108-1116, 1990.
61. PENIT-SORIA, J., AUDINAT, E. AND CREPEL, F.: Excitation of rat prefrontal cortical neurons by dopamine: An in vitro electrophysiological study. Brain Res. 425: 263-274, 1987.
62. POZZI, L., INVERNIZZI, R., CERVO, L., VALLEBUONA, F. AND SAMANIN, R.: Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem. 63: 195-200, 1994.
63. PYCOCK, C. J., CARTER, C. J. AND KERWIN, R. W.: Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J. Neurochem. 34: 91-99, 1980a.
64. PYCOCK, C. J., KERWIN, R. W. AND CARTER, C. J.: Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature (Lond.) 286: 74-76, 1980b.
65. RADCLIFFE, R. A. AND ERWIN, V. G.: Neurotensin reverses locomotor inhibition produced by microinjections of GBR-12909 into the medial prefrontal cortex. Soc. Neurosci. Abstr. 20: p. 1349, 1994.
66. 3H]SCH 23390. Brain Res. 375: 291-301, 1986.
67. SESACK, S. R. AND BUNNEY, B. S.: Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: A microiontophoretic study. J. Pharmacol. Exp. Ther. 248: 1323-1333, 1989.
68. SLOTNICK, B. M. AND LEONARD, C. M.: Stereotaxic Atlas of the Albino Mouse Forebrain, Department of Health Education and Welfare Publication (ADN)75-100, 1975.
69. STEWART, R. J., MORENCY, M. A. AND BENINGER, R. J.: Differential effects of intrafrontocortical microinjections of dopamine agonists and antagonists on circling behavior of rats. Behav. Brain Res. 17: 67-72, 1985.
70. STUDLER, J. M., KITABGI, P., TRAMU, G., HERVE, D., GLOWINSKI, J. AND TASSIN, J. P.: Extensive co-localization of neurotensin with dopamine in rat mesocortico-frontal dopaminergic neurons. Neuropeptides 11: 95-100, 1988.
71. SWERDLOW, N. R., VACCARINO, F. J., AMALRIC, M. AND KOOB, G. F.: The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings. Pharmacol. Biochem. Behav. 25: 233-48, 1986.
72. TASSIN, J. P., SIMON, H., GLOWINSKI, J. AND BOCKAERT, J.: Modulations of the sensitivity of dopaminergic receptors in the prefrontal cortex and the nucleus accumbens: Relationship with locomotor activity. In Brain Neurotransmitters and Hormones, ed. by R. Collu, J. R. Ducharme, A. Barbeau and G. Tolis, pp. 17-30, Raven Press, New York, 1982.
73. TASSIN, J. P., TROVERO, F., HERVE, D., BLANC, G. AND GLOWINSKI, J.: Mesocortical dopamine-neurotensin neurons. Possible opposite role of noradrenergic pathways on heteroregulations of dopamine (D1) and neurotensin postsynaptic receptors in the rat prefrontal cortex. Ann. N.Y. Acad. Sci. 668: 205-216, 1992.
74. THIERRY, A. M., TASSIN, J. P., BLANC, G. AND GLOWINSKI, J.: Selective activation of mesocortical DA system by stress. Nature (Lond.) 263: 242-244, 1976.
75. UHL, G. R. AND SNYDER, S. H.: Neurotensin receptor binding, regional and subcellular distributions favor transmitter role. Eur. J. Pharmacol. 41: 89-91, 1977.
76. VEZINA, P., BLANC, G., GLOWINSKI, J. AND TASSIN, J.-P.: Opposed behavioral outputs of increased dopamine transmission in prefrontocortical and subcortical areas: A role for the cortical D-1 dopamine receptor. Eur. J. Neurosci. 3: 1001-1007, 1991.
77. VEZINA, P., BLANC, G., GLOWINSKI, J. AND TASSIN, J. P.: Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on preand postsynaptic indices of dopamine function in the nucleus accumbens. Synapse 16: 104-112, 1994.
78. VINCENT, S. L., KHAN, Y. AND BENES, F. M.: Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex. J. Neurosci. 13: 2551-2564, 1993.
79. WALAAS, I.: Biochemical evidence for overlapping neocortical and allocortical glutamate projections to the nucleus accumbens and rostral caudatoputamen in the rat brain. Neuroscience 6: 399-405, 1981.
80. WALAAS, I. AND FONNUM, F.: The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat. Neuroscience 4: 209-216, 1979.
81. WOLF, M. E., GALLOWAY, M. P. AND ROTH, R. H.: Regulation of dopamine synthesis in the medial prefrontal cortex: Studies in brain slices. J. Pharmacol. Exp. Ther. 236: 699-707, 1986.
82. WOLF, M. E. AND ROTH, R. H.: Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors. Neuropharmacology 26: 1053-1059, 1987.